Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long-term epidemiology of multiple sclerosis in the Northern Seville District.
Differential modulation of the juxtaparanodal complex in Multiple Sclerosis.
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
Comments on "first-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis"
Serum vitamin d levels in Indian patients with multiple sclerosis.
Role of toll-like receptors in multiple sclerosis.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Yes.
Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood brain barrier.
Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation.
Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells.
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study.
Disease-related and functional predictors of employment status among adults with multiple sclerosis.
CD19 mRNA quantification improves rituximab treatment-to-target approach: A proof of concept study.
Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.
Characterization of Multiple Sclerosis Plaques Using Susceptibility-Weighted Imaging at 1.5 T: Can Perivenular Localization Improve Specificity of Imaging Criteria?
Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.
Myelin basic protein induces neuron-specific toxicity by directly damaging the neuronal plasma membrane.
Dimethyl fumarat - a new player in oral treatment options for relapsing forms of multiple sclerosis.
Therapeutic options in neuromyelitis optica spectrum disorders.
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.
Updated views on autologous hematopoietic stem cell transplantation for treatment of multiple sclerosis.
Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.
The cost of medication and the cost of treatment are not the same thing for multiple sclerosis.
Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders.

Pages